Hello Heart provides cardiovascular digital therapeutics to help people understand and improve their heart health using technology.
Hello Heart has raised $70.0M in total funding. The most recent round was Series D. The last funding was announced in May 2022.
Hello Heart's investors include Khosla Ventures, IVP, BlueRun Ventures, AAF Management Ltd., Maven Ventures.
Hello Heart is headquartered in Menlo Park, United States.
Hello Heart provides cardiovascular digital therapeutics to help people understand and improve their heart health using technology.
Hello Heart is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hello Heart — Funding & Investors." VCBacked, May 2, 2022, https://www.vcbacked.co/company/hello-heart. Accessed July 19, 2026.
VCBacked. (2022). Hello Heart — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/hello-heart
{{cite web |title=Hello Heart — Funding & Investors |url=https://www.vcbacked.co/company/hello-heart |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated